Rick Panning, MBA, MLS(ASCP)CM, has been in laboratory leadership positions for over 30 years, including most recently as Senior Administrative Director of Laboratory Services for HealthPartners and Park Nicollet in Minneapolis-St. Paul, Minnesota (leadership for 6 hospital laboratories, clinic laboratories for two large medical groups, and a central laboratory). Previously, he served as Vice President of Business Development at Fairview Health Services (supporting Laboratory, Imaging, Pharmacy, and Rehab Services) and Vice President for Laboratory Services at Allina Hospitals and Clinics, an integrated health system with 10 hospitals and 70 clinic laboratories in Minnesota. For 12 years, he was President of Laboratories for Fairview Health Services in Minneapolis and also served as Chief Executive Officer of the American Red Cross blood services in the North Central region. Rick has been very active in the laboratory profession, especially within the American Society for Clinical Laboratory Science (ASCLS), where he has served as a state president, regional director, and president of the national society. Currently, Rick is a member of the ASCLS Government Affairs Committee and is Past Chair of the Coordinating Council for the Clinical Laboratory Workforce (CCCLW). Rick received his BS in clinical laboratory science from Mankato State University and his MBA from the University of St. Thomas.
Victor Waddell, PhD, is currently the Laboratory Director of the Arizona State Public Health Laboratory in Phoenix, Arizona. He earned his PhD in Molecular Biology and Genetics at Queen’s University Belfast, Northern Ireland. Dr. Waddell’s other degrees include an MS in Environmental Sciences and a BS in Biological Sciences, also from Queen’s University Belfast. He has published many journal articles and co-authored book chapters relating to both public health and molecular biology. Dr. Waddell has worked for the Arizona State Public Health Laboratory since 2001 and was appointed as Laboratory Director in May 2004. As Laboratory Director, he is responsible for overseeing the entire laboratory, including the Analytical Chemistry, Microbiology, Newborn Screening, BioEmergency Response, and Chemical Emergency Response Sections at the state laboratory. He was part of the design-build team that led the development and planning of the new Arizona State Public Health Laboratory. Dr. Waddell currently serves as the Executive Director for the Arizona Biomedical Research Centre. Dr. Waddell served a three-year term as a Member-at-Large on the Association of Public Health Laboratories (APHL) Board of Directors from 2006 to 2009 and served as APHL President from 2011 to 2012. Dr. Waddell currently serves on several APHL committees and is the Co-Chair for the Joint Leadership Committee of the Laboratory Response Network formed by the Centers for Disease Control and Prevention, APHL, and the Federal Bureau of Investigation in 1999. Dr Waddell has served on the CLSI Board of Directors since 2014.
Nancy Anderson, MMSc, MT(ASCP), is the Senior Advisor for Clinical Laboratories, Division of Laboratory Systems at the Centers for Disease Control and Prevention (CDC). In this capacity she manages a number of CDC’s responsibilities under the Clinical Laboratory Improvement Amendments (CLIA) program that oversees medical laboratory testing in the United States in collaboration with the Centers for Medicare & Medicaid Services and the US Food and Drug Administration. Previously, she served as a Branch Chief in the same Division, with many of the same responsibilities she held in the CLIA program. She has contributed to developing quality standards for approximately 10 CLIA regulations and several guidelines promoting good laboratory practices. Ms. Anderson’s clinical laboratory experience includes her work in hospital laboratories in New York, Florida, and Georgia, in the CDC Special Bacteriology Reference Laboratory, and serving as the Coordinator for Emory University’s Master of Medical Science (MMSc) degree programs in the clinical laboratory sciences.
Ms. Anderson holds an MMSc degree in Clinical Microbiology from Emory University and is certified as a Medical Technologist by the American Society for Clinical Pathology. She is active in CLSI, where she chaired the subcommittee that developed M50, was a member of the document development committee for M52, and was a member of the Consensus Committee on Microbiology from 2009 to 2013.